Vedere aims to restore vision in patients with photoreceptor-based vision loss. Vedere was acquired by Novartis in 2020.
Location: United States, Massachusetts, Cambridge
Total raised: $77M
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 18.05.2021 | Series A | $77M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 01.08.2023 | Startups shutting down in 2023: Tech startups that closed up... | It is undeniable that 2023 has been a challenging year for tech startups across the globe. The initi... | techstartu... |
| 22.06.2021 | Vedere Bio II Announces Appointment of Gabor Veres, Ph.D., a... | CAMBRIDGE, Mass., June 22, 2021 /PRNewswire/ -- Vedere Bio II, Inc., a company developing next-gen... | prnewswire... |
| 18.05.2021 | Vedere Bio II Launches with $77 Million Series A Financing t... | CAMBRIDGE, Mass., May 18, 2021 /PRNewswire/ -- Vedere Bio II, Inc., a company developing next gene... | prnewswire... |
| 18.05.2021 | Vedere Bio II Secures $77M Series A Funding | CAMBRIDGE, MA, Vedere Bio II today announced the completion of its $77 million Series A financing.... | vcnewsdail... |